• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.78% Nasdaq Down 1.13%

    Apricus Biosciences, Inc. (APRI)

    -NasdaqCM
    0.47 Down 0.03(5.11%) May 3, 4:00PM EDT
    Prev Close:0.50
    Open:0.50
    Bid:0.38 x 700
    Ask:0.54 x 2000
    1y Target Est:2.48
    Beta:-0.20571
    Earnings Date:May 9 - May 13 (Est.)
    Day's Range:0.46 - 0.50
    52wk Range:0.46 - 1.99
    Volume:346,676
    Avg Vol (3m):330,927
    Market Cap:29.04M
    P/E (ttm):N/A
    EPS (ttm):-0.71
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for APRI

    Comparison

    Symbol% ChgMkt Cap
    APRIDown 5.11%29.04M
    ADMPUp 5.19%134.49M
    PFEUp 2.74%208.67B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):6.07
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.25
    Quarterly EPS Est (Mar-16) :-0.09
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Apricus Biosciences, Inc., a biopharmaceutical company, focuses on the development and commercialization of products and product candidates in the areas of urology and rheumatology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback